PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21667030-0	2011	18F-fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts.	18f-fluorothymidine	0-19	thyroid stimulating hormone receptor	Mus musculus	20-23	
21667030-1	2011	We investigated whether 18F-fluorothymidine-positron-emission tomography/computed tomography (18F-FLT-PET/CT) is useful for the evaluation of the very early response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab therapy in human lung cancer xenografts.	18f-fluorothymidine	24-43	thyroid stimulating hormone receptor	Mus musculus	102-105